Search

Find exactly what you’re looking for.
Search

Topics
Service
Showing 1-20 of 64 results

Medical practices, dental practices and other health care entities must again comply with the federal Corporate Transparency Act (“CTA”). The deadline for compliance is March 21, 2025. What You Need to Know: The Corporate Transparency Act filing deadline is now March 21, 2025. Medical practices and...

​The CTA madness continues. On December 23, 2024, the U.S. Court of Appeals for the Fifth Circuit (the "Fifth Circuit"), in the case of Texas Top Cop Shop v. Garland ("Texas Top Cop Shop"), stayed the enforcement of an injunction issued by the U.S. District Court for the Eastern District of Texas...

On December 23, 2024, the U.S. Court of Appeals for the Fifth Circuit (“Fifth Circuit”) granted the U.S. Government’s motion to stay the nationwide preliminary injunction issued by U.S. District Court for the Eastern District of Texas (“District Court”) on December 3, 2024, which temporarily halted...

On April 23, 2024, the Federal Trade Commission (FTC) issued its proposed final rule (the “Rule”) banning the use of future noncompete agreements for all workers, including senior executives, 89 FR 38342. Noncompete agreements have long been a valuable tool in a company’s toolbox to mitigate the...

The decision of the Federal District Court for the Northern District of Alabama in the case of National Small Business United v. Yellen , announced on Friday, March 1, 2024, has created uncertainty for both reporting companies and their attorneys under the Corporate Transparency Act (“CTA”). What...

For all “reporting companies” created or registered on or after January 1, 2024, information concerning the “beneficial owners” of the reporting company must be reported to the Financial Crimes Enforcement Network (“FinCEN”) along with information concerning “company applicants.” As a result, both...

A 2023 update on corporate litigation in the Delaware Court of Chancery, as well as an update on the annual amendments made to the General Corporation Law of the State of Delaware and alternative entity acts, which were all effective as of August 1, 2023. The material statutory amendments discussed...

“Company applicants” — the term may sound vague, but the identities of “company applicants” of reporting companies are just as important under the new federal Corporate Transparency Act (the “CTA”) as the identities of the beneficial owners of those companies. What You Need to Know: The era of...

Beginning on January 1, 2024, the Corporate Transparency Act (the “CTA”) will require all “Reporting Companies” to report to the federal Financial Claims Enforcement Network (“FinCEN”) information about their “beneficial owners” and “company applicant’s (“BOI Reports”). The statutory definition of a...

Counsel on Commercial Arrangements, Business Operations and Regulatory Matters Regardless of size or structure, health care providers, payors, entrepreneurs and businesses must navigate a complex maze of federal and state laws and regulations to remain economically competitive. Health care...

Ted Baines Headshot

Ted Baines is a partner and past chair of Saul Ewing's Litigation Department. He focuses his litigation practice on commercial contract, insurance, shareholder disputes, including shareholder demand responses, real estate, construction, and the defense of mass torts involving deaths or catastrophic...

Marshall B. Paul

Marshall Paul focuses his practice on counseling businesses, nonprofit organizations, health care concerns and professionals with respect to limited liability company matters, general corporate matters, joint ventures, acquisitions and sales, fiduciary duty issues and financings. His clients include...

Charles O. Monk, II

Charlie Monk handled complex, high-stakes litigation, but is now limiting his practice to strategic consulting assignments. During his 50 years as a trial lawyer, clients ranging from governmental entities and security broker dealers to energy providers and utilities have relied on his legal counsel...

Charles Kelly

Charles Kelly is a highly regarded litigator with extensive experience handling media, health care and complex commercial litigation. He regularly litigates cases in federal, state and bankruptcy courts. Charlie's clients range from Fortune 100 to small start-up companies that he represents for...

Charles M. Lizza

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...

Antitrust significantly impacts commercial business throughout the United States – from monopoly lawsuits against Big Tech to horizontal price-fixing cases to the development of antitrust compliance programs for start-ups. Irrespective of size, businesses must comply with antitrust laws, trade...

Stephanie Denker Headshot

Stephanie Denker focuses on complex commercial litigation, including insurance and securities law. In the Insurance industry, Stephanie has experience in lapse litigation, primarily in New York. Stephanie also defends insurance companies in class actions, including cases brought in Illinois, Florida...

Steven Appelbaum Headshot

Steven Appelbaum is an experienced commercial litigator who represents individuals and companies involved in disputes related to real estate, creditor’s rights, corporate divorces, employment matters, and theft of trade secrets. Steven enjoys gaining a deep understanding of his clients’ business...

William T. Eveland

With successes in state, federal, and appellate courts across the country, Toby Eveland is a skilled litigator that clients often retain when their reputation is on the line and when they are involved in high-profile cases that could affect their viability. Toby's nationwide litigation practice...

For More Information
Contact us